CN Patent

CN102421288A — 前列环素类似物的固体剂型

Assigned to United Therapeutics Corp · Expires 2012-04-18 · 14y expired

What this patent protects

中等湿度水平(例如大于3％但小于等于7％)可以是对一些前列环素类似物的固体剂型有益的。因此，含有前列环素类似物的固体剂型可包装在具有一定量的干燥剂的药物包装内部，从而在储存之后，所述固体剂型内可具有中等湿度水平。

USPTO Abstract

中等湿度水平(例如大于3％但小于等于7％)可以是对一些前列环素类似物的固体剂型有益的。因此，含有前列环素类似物的固体剂型可包装在具有一定量的干燥剂的药物包装内部，从而在储存之后，所述固体剂型内可具有中等湿度水平。

Drugs covered by this patent

treprostinil-diolamine (TREPROSTINIL DIOLAMINE)

Patent Metadata

Patent number: CN102421288A
Jurisdiction: CN
Classification: —
Expires: 2012-04-18
Drug substance claim: No
Drug product claim: No
Assignee: United Therapeutics Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.